23andMe launches genome service in the U.K.

23andMe Inc. (Mountain View, Calif.) launched its Personal Genome Service (PGS) in the U.K.

Last year, 23andMe halted sales of the service in the U.S. after an FDA warning letter said 23andMe was marketing its product for "medical device uses," for which it does not have FDA clearance or approval (see BioCentury Extra, Dec. 6, 2013). ...